Genpact CEO Warns of AIDriven IT Workload Reduction and Slower Hiring in India
Stellantis Unveils 70 Billion DecadeLong Strategy Commits to 60 New Models
SpaceX Successfully Launches Starship Test Flight After Initial Scrub
The AI Economy Reshapes the American Dream BlueCollar Skilled Trades Emerge as a Growth Sector
Chinese Carmakers Double EU Market Share as Electric Vehicle Sales Surge
European AI Stocks Buck Broader Market Gloom Amid Heightened Geopolitical Risks
Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline
GEGGL Q1 2026 Earnings Significant EPS Miss with No Revenue Reported
Traws Pharma Q1 2026 Earnings Narrower Than Expected Loss Despite No Revenue
HF Foods Group Inc HFFG Q1 2026 Earnings EPS Soars Past Estimates by 175 but Stock Slips
ASBA Q1 2026 Earnings Subordinated Notes Benefit from EPS Beat as Associated BancCorp Reports Solid Quarter
DBX Q1 2026 Earnings EPS Beat Signals Resilience Despite Revenue Uncertainty
Digital Brands Group DBGI Surges 157 as Buyers Defend Key 039 Support
RDACR Rights Remain Steady at 012 as Speculative Interest Holds
Xperi Inc XPER Edges Higher in Quiet Trading Key Levels in Focus
NexGel Inc NXGL Shows Modest Gains Trading Near Support Levels
Neuberger High Yield Strategies Fund NHS Edges Higher as IncomeFocused Investors Return
Setting Up Brokerage Accounts for Grandkids in a Parents Name Potential Pitfalls and Strategic Considerations
USPH Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Despite Operational Consistency
Atomera ATOM Surges Over 31 as Semiconductor Technology Stock Gains Momentum
XIFR Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength
RadNet Inc RDNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb
SPME Q1 2026 Earnings EPS Misses Estimates by Nearly 20 as Preferred Shares Edge Lower
Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Quiet Revenue Disclosure
LCTX Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue
CHEF Q1 2026 Earnings Earnings Surge Past Expectations with 55 Surprise